Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Berlin - Delayed Quote EUR

Faron Pharmaceuticals Oy (4FR.BE)

Compare
2.4400
+0.1400
+(6.09%)
At close: April 17 at 7:27:06 PM GMT+2
Loading Chart for 4FR.BE
  • Previous Close 2.3000
  • Open 2.3000
  • Bid 2.2650 x --
  • Ask 2.6150 x --
  • Day's Range 2.3000 - 2.4850
  • 52 Week Range 1.0540 - 3.3550
  • Volume 0
  • Avg. Volume 0
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Feb 27, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: 4FR.BE

View More

Performance Overview: 4FR.BE

Trailing total returns as of 4/17/2025, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .

YTD Return

4FR.BE
1.01%
FTSE 100 (^FTSE)
1.26%

1-Year Return

4FR.BE
74.04%
FTSE 100 (^FTSE)
5.45%

3-Year Return

4FR.BE
40.20%
FTSE 100 (^FTSE)
8.66%

5-Year Return

4FR.BE
43.26%
FTSE 100 (^FTSE)
43.00%

Compare To: 4FR.BE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 4FR.BE

View More

Valuation Measures

Annual
As of 4/17/2025
  • Market Cap

    272.13M

  • Enterprise Value

    274.74M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    161.70

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 4FR.BE

View More

Company Insights: 4FR.BE

Research Reports: 4FR.BE

View More